Hostname: page-component-5c6d5d7d68-wbk2r Total loading time: 0 Render date: 2024-08-20T13:12:04.298Z Has data issue: false hasContentIssue false

Psychiatric nurses’ attitudes to antipsychotic depot injections

Published online by Cambridge University Press:  16 April 2020

L. Mnif
Affiliation:
Psychiatry A, Hedi Chaker University Hospital, Sfax, Tunisia
J. Masmoudi
Affiliation:
Psychiatry A, Hedi Chaker University Hospital, Sfax, Tunisia
I. Baâti
Affiliation:
Psychiatry A, Hedi Chaker University Hospital, Sfax, Tunisia
C. Hachicha
Affiliation:
Psychiatry A, Hedi Chaker University Hospital, Sfax, Tunisia
N. Charfi
Affiliation:
Psychiatry A, Hedi Chaker University Hospital, Sfax, Tunisia
A. Jaoua
Affiliation:
Psychiatry A, Hedi Chaker University Hospital, Sfax, Tunisia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The use of conventional depots (CDs) continues to have a great importance in our psychiatric sectors due to the unavailability of atypical depot formulations.

Objective

The aim of this work was to assess psychiatric nurses’ perspectives of CDs.

Methods

Forty nurses from our psychiatric department completed a questionnaire which included both open and multiple choice questions concerning the following topics:

  1. - CDs and improvement in adherence to treatment,

  2. - efficacy and tolerance of CDs,

  3. - interest and indications of CDs.

Results

  1. * Psychiatric nurses (PNs) reported that CDs allowed avoidance of oblivion (83%) and regular intake of treatment (54%). But, several PNs believed that the injections of CDs were complex (67%) and the majority considered that CDs did not have positive impact on patient adherence (85%).

  2. * PNs thought that CDs :

  1. - were more effective (fewer relapses 56%) and better tolerated than oral formulations.

  2. - did not require more precautions (80%).

  3. - provided more security to the patient (no risk of toxicity 97%).

  1. * PNs reported lots of indications: lack of family support (75%), multiple relapses (72%), poor adherence (70%) and self or hetero-aggressive behavior at relapse (52%).

They supported the advantages of CDs: improving social life (85%) and patient's autonomy (68%) and permitting remission (25%).

Conclusion

The findings suggest that PNs have positive attitude towards efficacy and tolerance of CDs but negative ideas about their indications, which could be the cause of patient stigmatization. That's why providing a clear piece of information seems necessary.

Type
P03-89
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.